Methamphetamine Hydrochloride NDC 75907-094

NDC codes

FDA NDC Directory

Product NDC (as listed)75907-094Labeler and product segments. Claims need a package NDC.

Product NDC at billing width75907-0094Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
75907-094-01	75907009401	100 TABLET in 1 BOTTLE, PLASTIC (75907-094-01)Marketed from Nov 7, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Methamphetamine Hydrochloride
Generic name (nonproprietary): methamphetamine hydrochloride
Active ingredients: Methamphetamine hydrochloride — 5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Dr. Reddy's Laboratories Inc
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 091189
Marketing start: Nov 7, 2025
Listing expires: Dec 31, 2026
DEA schedule: CII
Other FDA classes: Amphetamines (Chemical structure)Appetite Suppression (Physiologic effect)Central Nervous System Stimulation (Physiologic effect)Increased Sympathetic Activity (Physiologic effect)
Identifiers: Product ID 75907-094_c77198dd-fd98-ac84-9754-517e77c5c729SPL ID c77198dd-fd98-ac84-9754-517e77c5c729SPL set ID d0905e2c-a02f-ec4f-59a3-6f7ad0acbbf6RxCUI 977860UNII 997F43Z9CVUPC 0375907094019
Pharmacologic class: Amphetamine Anorectic; Central Nervous System Stimulant

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N475907009401 followed by a unit qualifier and the quantity

Package 75907-0094-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 7, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

1. INDICATIONS AND USAGE Methamphetamine hydrochloride tablets, USP is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in pediatric patients 6 years of age and older. Methamphetamine hydrochloride tablets, USP is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in pediatric patients 6 years of age and older.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 091189

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 091189
Product	Strength	Form · route	Labeler	Product NDC
Methamphetamine Hydrochloride	Methamphetamine hydrochloride 5 mg/1	TabletOral	Mayne Pharma Commercial LLC	68308-115